Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
H., & Sternquist, M
Reasons for discontinuation of obesity pharmacotherapy with semaglutide or Tirzepatide in clinical practice
If the dosage is given more than the required amount, it may cause certain adverse effects to the body
Such recommendations often involve modifying eating behaviors and increasing physical activity to reduce net caloric intake
The risk is not established at the doses and durations used in clinical peptide protocols, but the theoretical basis for the concern is real and should not be minimized
If a simple finger-prick can be used instead of a conventional blood draw to collect blood samples from tens of thousands of peopleperhaps multiple times per personthe use of at-home blood collection kits could be a significant benefit
